Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Comparison Table: BPC-157 vs. BPC-159 at a Glance

To make this even clearer, our team put together a straightforward comparison. This is the kind of high-level overview we use internally when evaluating new compounds. Amino Acid Length 15 amino acids (Pentadecapeptide) 17 amino acids (Heptadecapeptide) Struct

This comparison does not assign a generated winner or score.

  • To make this even clearer, our team put together a straightforward comparison. This is the kind of high-level overview we use internally when evaluating new compounds.
  • Amino Acid Length
  • 15 amino acids (Pentadecapeptide)
  • 17 amino acids (Heptadecapeptide)
  • Structural Basis
  • Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
  • BPC-157 sequence + Lysine-Proline (LP) at the C-terminus (Theoretical)
  • Origin
  • Derived from a protein in human gastric juice
  • A synthetic modification of BPC-157
  • Volume of Research
  • Extensive (hundreds of preclinical studies)
  • Extremely limited to virtually non-existent
  • Known Mechanisms
  • Angiogenesis (VEGF), Nitric Oxide modulation, F-actin interaction
  • Entirely speculative; no published data
  • Primary Research Areas
  • Tendon/ligament repair, muscle injury, gut health, anti-inflammatory
  • Undefined; claims often mirror BPC-157 without evidence
  • Supplier Reliability
  • Established standards; verifiable purity from reputable sources
  • Highly variable; significant risk of low purity or incorrect product
  • Status in Research
  • A well-established, foundational research tool
  • A highly experimental, unverified compound
More references

Related material

Comparison

Amino Acid Sequence Comparison

BPC-157 sequence: GEPPPGKPADDAGLV (15 residues) BPC-159 has a different, shorter sequence of 11 residues. The exact published sequence for BPC-159 varies between commercial source…

View details →